GSK, others eyeing acquisition of Brazil's 4th largest drugmaker

02/12/2013 | Reuters

Several drugmakers, including GlaxoSmithKline and likely Novartis, Pfizer and Abbott Laboratories, are looking at acquiring Brazil's Ache Laboratorios Farmaceuticos for up to $4 billion to increase their share in Latin America's pharmaceutical industry. Ache is the fourth-largest drugmaker in Brazil, but it ranks first in prescription drugs and is growing its over-the-counter business.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY